Company: HVIIR
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010497
Chunk: 18

Company: Hennessy Capital Investment Corp. VII
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 18
---
 their redemption rights with respect to their founder shares and private placement shares
in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association
(A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with its Business Combination
or to redeem 100% of the public shares if the Company has not consummated a Business Combination within the Completion Window or (B) with
respect to any other material provisions relating to shareholders’ rights or pre-Business Combination activity; (iii) waive their
rights to liquidating distributions from the Trust Account with respect to their founder shares and private placement shares if the Company
fails to complete its Business Combination within the Completion Window, although they will be entitled to liquidating distributions from
the Trust Account with respect to any public shares they hold if the Company fails to complete its Business Combination within the Completion
Window and to liquidating distributions from assets outside the Trust Account; and (iv) vote any founder shares or private placement shares
held by them and any public shares purchased during or after the Initial Public Offering (including in open market and privately-negotiated
transactions, aside from shares they may purchase in compliance with the requirements of Rule 14e-5 under the Exchange Act, which would
not be voted in favor of approving a Business Combination) in favor of a Business Combination.

NOTE 5 — RELATED PARTY TRANSACTIONS

Founder Shares

On
October 8, 2024, the Sponsor made a capital contribution of $25,000,
or approximately $0.004
per share, for which the Company issued 5,750,000
founder shares to the Sponsor. On January 10, 2025, the Company issued an additional 958,333
founder shares (up to 125,000
shares of which were subject to forfeiture depending on the extent to which the Underwriters’ over-allotment option is
exercised) for no additional consideration, resulting in the Sponsor holding a total of 6,708,333
founder shares (up to 875,000
of which are subject to forfeiture by the holders thereof depending on the extent to which the Underwriters’ option to
purchase additional Units is exercised). All share and per share data have been retrospectively presented. On January 21, 2025, the
Underwriters partially exercised their over-allotment option and forfeited the unexercised balance. As a result of